Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Director/PDMR Shareholding

23 Aug 2005 17:12

Elan Corporation PLC23 August 2005 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). 1. Name of the issuer ELAN CORPORATION PLC 2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a);or (ii) (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance withsection 324 (as extended by section 328) of the Companies Act 1985 TRANSACTIONNOTIFIED IN ACCORDANCE WITH DR 3.1.4R(1)(b); TRANSACTION NOTIFIED IN ACCORDANCEWITH SECTION 53 OF THE IRISH COMPANIES ACTS 1990; or (iii) (iii) both (i) and (ii) 3. Name of person discharging managerial responsibilities/director GAROARMEN 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person NO 5. Indicate whether the notification is in respect of a holding of theperson referred to in 3 or 4 above or in respect of a non-beneficial interestBENEFICIAL 6. Description of shares (including class), debentures orderivatives or financial instruments relating to shares ORDINARY SHARES OF €0.05EACH REPRESENTED BY AMERICAN DEPOSITARY SHARES 7. Name of registered shareholder(s) and, if more than one, the number ofshares held by each of them PERSON NAMED IN 3 ABOVE 8 State the nature of the transaction PURCHASE - ie EXERCISE OF 200,000 SHARE OPTIONS AND SALE OF 200,000 ADSs 9 Number of shares, debentures or financial instruments relating toshares acquired 200,000 AT $3.84 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.047% 11. Number of shares, debentures or financial instruments relating to sharesdisposed 200,000 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.047% 13. Price per share or value of transaction $8.2452 14. Date and place of transaction 19 AUGUST 2005 - NEW YORK STOCK EXCHANGE 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 270,000 - BENEFICIAL 0.063% 16. Date issuer informed of transaction 22 AUGUST 2005 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant 18. Period during which or date on which it can be exercised 19. Total amount paid (if any) for grant of the option 20. Description of shares or debentures involved (class and number) 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 22. Total number of shares or debentures over which options held followingnotification 23. Any additional information NONE 24. Name of contact and telephone number for queries LIAM DANIEL: 017094621 Name and signature of duly authorised officer of issuer responsible for makingnotification LIAM DANIEL - COMPANY SECRETARY Date of notification 22 AUGUST 2005 This announcement has been issued through the Companies Announcement Service of The Irish Stock Exchange This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.